FDA Import Refusal SCS-7035009-9/11/1 — MID EAST CANADIAN PHARMACEUTICAL

MID EAST CANADIAN PHARMACEUTICAL — FEI 3032948197

The FDA refused shipment SCS-7035009-9/11/1 from MID EAST CANADIAN PHARMACEUTICAL (Canada) on Jan 3, 2025. The refused product falls under Drugs and Biologics — POTASSIC SALINE (INJECTION) (REPLENISHER). Cited charges: 118,3280,75

Refusal details

Date
Jan 3, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
65RAY12 POTASSIC SALINE (INJECTION) (REPLENISHER)
Charges
118,3280,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.